MT45 Cost-Effectiveness Analysis of Left Atrial Appendage Closure (LAAC) Device Vesus Warfarin and New Oral Anticoagulants (NOACS) in Patients with Atrial Fibrillation (AF) - Large Brazilian Healthcare Payer Perspective
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1690
https://www.valueinhealthjournal.com/article/S1098-3015(23)01790-4/fulltext
Title :
MT45 Cost-Effectiveness Analysis of Left Atrial Appendage Closure (LAAC) Device Vesus Warfarin and New Oral Anticoagulants (NOACS) in Patients with Atrial Fibrillation (AF) - Large Brazilian Healthcare Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01790-4&doi=10.1016/j.jval.2023.03.1690
First page :
Section Title :
Open access? :
No
Section Order :
11076